NCT02763137View on ClinicalTrials.gov

Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Parkinson Disease
Interventions
DRUG

Standard LD/CD

LD/CD will be administered at patient's usual dose and frequency during 8 hours interval

DRUG

Semi continuous intra-oral administration of LD/CD

Semi continuous intra-oral administration of standard LD/CD at a dose equal to the total dose of standard oral LD/CD that patients would normally consume over 8 hours period.

Trial Locations (1)

00163

Irccs San Raffaele Pisana, Rome

All Listed Sponsors
collaborator

SynAgile Corporation

INDUSTRY

lead

IRCCS San Raffaele Roma

OTHER

NCT02763137 - Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients | Biotech Hunter | Biotech Hunter